Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition

Recently, a novel coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised global concerns, being the etiological agent of the current pandemic infectious coronavirus disease 2019 (COVID-19). Specific prophylactic treatments like vaccines, have been authorized f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanna, Vanna, Satta, Sandro, Hsiai, Tzung, Sechi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755562/
https://www.ncbi.nlm.nih.gov/pubmed/35114539
http://dx.doi.org/10.1016/j.ejmech.2022.114121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755562/
https://www.ncbi.nlm.nih.gov/pubmed/35114539
http://dx.doi.org/10.1016/j.ejmech.2022.114121

Ejemplares similares